Selection of reprogramming factors of induced pluripotent stem cells based on the protein interaction network and functional profiles

Protein and Peptide Letters

Volumn 19, Issue 1, 2012, Pages 113-119

  Huang, Tao ^c,d   Cai, Yu Dong ^a,b,h   Chen, Lei ^g   Hu, Le Le ^a   Kong, Xiang Yin ^e,f   Li, Yi Xue ^c,d   Chou, Kuo Chen ^h  

^a SHANGHAI UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Chinese Academy of Sciences   (China)

^d SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

^g EAST CHINA NORMAL UNIVERSITY   (China)

^h GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

Disease investigation; Gene functional profiles; Protein interaction network; Reprogramming factors; Stem cells

Indexed keywords

BETA CATENIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MYC PROTEIN; STAT3 PROTEIN;

ARTICLE; CONTROLLED STUDY; EMBRYO; FBXO15 GENE; GENE; GENE FUNCTION; GENE POOL; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC SELECTION; HUMAN; KLF4 GENE; MATHEMATICAL COMPUTING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PLURIPOTENT STEM CELL; POU5FL GENE; PROCESS OPTIMIZATION; PROTEIN FUNCTION; PROTEIN INTERACTION; SOMATIC CELL GENETICS; SOX2 GENE; SYSTEMS BIOLOGY;

EID: 84863283565     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986612798472884     Document Type: Article

References (47)

1. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4), 663-76. (Pubitemid 44233629)
2. Welstead, G. G.; Schorderet, P.; Boyer, L. A. The reprogramming language of pluripotency. Curr. Opin. Genet. Dev., 2008, 18(2), 123-129. (Pubitemid 351749825)
3. Tokuzawa, Y.; Kaiho, E.; Maruyama, M.; Takahashi, K.; Mitsui, K.; Maeda, M.; Niwa, H.; Yamanaka, S., Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell Biol., 2003, 23 (8), 2699-708. (Pubitemid 36403071)
4. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 2007, 1(1), 55-70.
5. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature, 2007, 448(7151), 313-7. (Pubitemid 47080336)
6. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B. E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 2007, 448(7151), 318-24. (Pubitemid 47080337)
7. Esteban, M. A.; Wang, T.; Qin, B.; Yang, J.; Qin, D.; Cai, J.; Li, W.; Weng, Z.; Chen, J.; Ni, S.; Chen, K.; Li, Y.; Liu, X.; Xu, J.; Zhang, S.; Li, F.; He, W.; Labuda, K.; Song, Y.; Peterbauer, A.; Wolbank, S.; Redl, H.; Zhong, M.; Cai, D.; Zeng, L.; Pei, D. Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem Cells. Cell Stem Cell, 2009.
8. Hong, H.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Kanagawa, O.; Nakagawa, M.; Okita, K.; Yamanaka, S., Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 2009, 460(7259), 1132-5.
9. Huangfu, D.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Snitow, M.; Chen, A. E.; Melton, D. A., Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 2008, 26(7), 795-7. (Pubitemid 351961456)
10. Lin, T.; Ambasudhan, R.; Yuan, X.; Li, W.; Hilcove, S.; Abujarour, R.; Lin, X.; Hahm, H. S.; Hao, E.; Hayek, A.; Ding, S. A chemical platform for improved induction of human iPSCs. Nat. Methods, 2009, 6(11), 805-8.
11. Yamanaka, S. Elite and stochastic models for induced pluripotent stem cell generation. Nature, 2009, 460(7251), 49-52.
12. Yoshida, Y.; Takahashi, K.; Okita, K.; Ichisaka, T.; Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 2009, 5(3), 237-241.
13. Zhao, Y.; Yin, X.; Qin, H.; Zhu, F.; Liu, H.; Yang, W.; Zhang, Q.; Xiang, C.; Hou, P.; Song, Z.; Liu, Y.; Yong, J.; Zhang, P.; Cai, J.; Liu, M.; Li, H.; Li, Y.; Qu, X.; Cui, K.; Zhang, W.; Xiang, T.; Wu, Y.; Liu, C.; Yu, C.; Yuan, K.; Lou, J.; Ding, M.; Deng, H. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell, 2008, 3(5), 475-9.
14. Huang, J.; Chen, T.; Liu, X.; Jiang, J.; Li, J.; Li, D.; Liu, X. S.; Li, W.; Kang, J.; Pei, G. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Cell Res., 2009, 19(10), 1127-38.
15. de Souza, N., Primer: induced pluripotency. Nat. Methods, 2010, 7(1), 20-1.
16. Carr, A. J.; Vugler, A. A.; Hikita, S. T.; Lawrence, J. M.; Gias, C.; Chen, L. L.; Buchholz, D. E.; Ahmado, A.; Semo, M.; Smart, M. J.; Hasan, S.; da Cruz, L.; Johnson, L. V.; Clegg, D. O.; Coffey, P. J. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One, 2009, 4(12), e8152.
17. Zhang, J.; Wilson, G. F.; Soerens, A. G.; Koonce, C. H.; Yu, J.; Palecek, S. P.; Thomson, J. A.; Kamp, T. J., Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res., 2009, 104(4), e30-41.
18. Fortunel, N. O.; Otu, H. H.; Ng, H. H.; Chen, J.; Mu, X.; Chevassut, T.; Li, X.; Joseph, M.; Bailey, C.; Hatzfeld, J. A.; Hatzfeld, A.; Usta, F.; Vega, V. B.; Long, P. M.; Libermann, T. A.; Lim, B. Comment on " 'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science, 2003, 302(5644), 393; author reply 393.
19. Ivanova, N. B.; Dimos, J. T.; Schaniel, C.; Hackney, J. A.; Moore, K. A.; Lemischka, I. R., A stem cell molecular signature. Science, 2002, 298(5593), 601-4.
20. Ramalho-Santos, M.; Yoon, S.; Matsuzaki, Y.; Mulligan, R. C.; Melton, D. A., "Stemness": transcriptional profiling of embryonic and adult stem cells. Science, 2002, 298(5593), 597-600. (Pubitemid 35215313)
21. Jensen, L. J.; Kuhn, M.; Stark, M.; Chaffron, S.; Creevey, C.; Muller, J.; Doerks, T.; Julien, P.; Roth, A.; Simonovic, M.; Bork, P.; von Mering, C. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res., 2009, 37(Database issue), D412-6.
22. Snel, B.; Lehmann, G.; Bork, P.; Huynen, M. A., STRING: a webserver to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res., 2000, 28(18), 3442-4.
23. von Mering, C.; Huynen, M.; Jaeggi, D.; Schmidt, S.; Bork, P.; Snel, B., STRING: a database of predicted functional associations between proteins. Nucleic Acids Res., 2003, 31(1), 258-61. (Pubitemid 36150379)
24. von Mering, C.; Jensen, L. J.; Kuhn, M.; Chaffron, S.; Doerks, T.; Kruger, B.; Snel, B.; Bork, P. STRING 7-recent developments in the integration and prediction of protein interactions. Nucleic Acids Res., 2007, 35 (Database issue), D358-62. (Pubitemid 46056231)
25. von Mering, C.; Jensen, L. J.; Snel, B.; Hooper, S. D.; Krupp, M.; Foglierini, M.; Jouffre, N.; Huynen, M. A.; Bork, P., STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res., 2005, 33(Database issue), D433-7. (Pubitemid 40207910)
26. Fitch, A. M.; Jones, M. B., Shortest path analysis using partial correlations for classifying gene functions from gene expression data. Bioinformatics, 2009, 25(1), 42-7.
27. Managbanag, J. R.; Witten, T. M.; Bonchev, D.; Fox, L. A.; Tsuchiya, M.; Kennedy, B. K.; Kaeberlein, M., Shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity. PLoS One, 2008, 3(11), e3802.
28. Zhou, X.; Kao, M. C.; Wong, W. H. Transitive functional annotation by shortest-path analysis of gene expression data. Proc. Natl. Acad. Sci. USA, 2002, 99(20), 12783-8.
29. Dijkstra, E. W., A note on two problems in connexion with graphs. Numerische Mathematik, 1959, 1, 269-271.
30. Chartrand, G.; Oellermann, O. R. Applied and Algorithmic Graph Theory. Mcgraw-Hill College: 1992.
31. Cormen, T. H.; Leiserson, C. E.; R.L., R.; Stein, C. Introduction to Algorithms (second ed.). MIT press and Mcgraw-Hill: 2001.
32. Freeman L. C. Centrality in social networks: Conceptual clarification. Social Networks 1979; 1, 215-239.
33. Giubellino, A.; Burke, T. R., Jr.; Bottaro, D. P. Grb2 signaling in cell motility and cancer. Expert Opin. Ther. Targets, 2008, 12(8), 1021-33.
34. Cheng, A. M.; Saxton, T. M.; Sakai, R.; Kulkarni, S.; Mbamalu, G.; Vogel, W.; Tortorice, C. G.; Cardiff, R. D.; Cross, J. C.; Muller, W. J.; Pawson, T. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell, 1998, 95(6), 793-803. (Pubitemid 29014459)
35. Sun, J.; Pedersen, M.; Bengtsson, S.; Ronnstrand, L. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl. Exp. Cell Res., 2007, 313(18), 3935-42. (Pubitemid 47561898)
36. Hamazaki, T.; Kehoe, S. M.; Nakano, T.; Terada, N., The Grb2/Mek pathway represses Nanog in murine embryonic stem cells. Mol. Cell Biol., 2006, 26(20), 7539-49. (Pubitemid 44547704)
37. Thompson, M. D.; Monga, S. P. WNT/beta-catenin signaling in liver health and disease. Hepatology, 2007, 45(5), 1298-305. (Pubitemid 46775794)
38. Wang, X.; Goode, E. L.; Fredericksen, Z. S.; Vierkant, R. A.; Pankratz, V. S.; Liu-Mares, W.; Rider, D. N.; Vachon, C. M.; Cerhan, J. R.; Olson, J. E.; Couch, F. J. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 2008, 17(8), 2101-8.
39. Saldanha, G.; Ghura, V.; Potter, L.; Fletcher, A. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br. J. Dermatol., 2004, 151(1), 157-164. (Pubitemid 39061293)
40. Takeda, K.; Noguchi, K.; Shi, W.; Tanaka, T.; Matsumoto, M.; Yoshida, N.; Kishimoto, T.; Akira, S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA, 1997, 94(8), 3801-4. (Pubitemid 27180453)
41. Matsuda, T.; Nakamura, T.; Nakao, K.; Arai, T.; Katsuki, M.; Heike, T.; Yokota, T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J., 1999, 18(15), 4261-9. (Pubitemid 29364128)
42. Bromberg, J. F.; Wrzeszczynska, M. H.; Devgan, G.; Zhao, Y.; Pestell, R. G.; Albanese, C.; Darnell, J. E., Jr. Stat3 as an oncogene. Cell, 1999, 98(3), 295-303. (Pubitemid 29380565)
43. Hirano, T.; Ishihara, K.; Hibi, M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene, 2000, 19(21), 2548-56. (Pubitemid 30339210)
44. Nesbit, C. E.; Tersak, J. M.; Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene, 1999, 18(19), 3004-16. (Pubitemid 29276540)
45. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA, 2003, 100(7), 3983-8. (Pubitemid 36418143)
46. Hanna, J.; Saha, K.; Pando, B.; van Zon, J.; Lengner, C. J.; Creyghton, M. P.; van Oudenaarden, A.; Jaenisch, R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature, 2009, 462(7273), 595-601.
47. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Slukvin, II; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318(5858), 1917-20.